Patents by Inventor Anat Oren

Anat Oren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8575107
    Abstract: Clusterin-derived peptides or homologues or derivatives thereof, pharmaceutical compositions including the same, methods of manufacturing the peptides, homologues, derivatives thereof and compositions including the same, and methods of treating conditions including administering the peptides, homologues, derivatives thereof and compositions including the same, are provided. Also provided are nucleotide sequences encoding the peptides, homologues, derivatives thereof and compositions including the same, antibodies directed to epitopes thereof and fusion proteins including the same.
    Type: Grant
    Filed: January 22, 2009
    Date of Patent: November 5, 2013
    Assignee: Compugen Ltd.
    Inventors: Yossef Kliger, Ofer Levy, Itamar Borukhov, Assaf Wool, Ehud Schreiber, Anat Amir, Zurit Levine, Zohar Tiran, Anat Oren, Amir Toporik
  • Patent number: 8512708
    Abstract: Provided is a gp96-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: August 20, 2013
    Assignee: Compugen Ltd.
    Inventors: Yossef Kliger, Ofer Levy, Itamar Borukhov, Anat Amir, Anat Oren
  • Publication number: 20110189188
    Abstract: Provided is a gp96-derived peptides or homologs or derivatives thereof, pharmaceutical composition including them, a use thereof for therapy and for the manufacture of a medicament, a method of treating a wide range of conditions, disorders and diseases therewith, nucleotide sequences encoding them, antibodies directed to epitopes thereof and fusion proteins including them.
    Type: Application
    Filed: March 12, 2009
    Publication date: August 4, 2011
    Applicant: COMPUGEN LTD.
    Inventors: Yossef Kliger, Ofer Levy, Itamar Borukhov, Anat Amir, Anat Oren
  • Publication number: 20100322938
    Abstract: Clusterin-derived peptides or homologues or derivatives thereof, pharmaceutical compositions including the same, methods of manufacturing the peptides, homologues, derivatives thereof and compositions including the same, and methods of treating conditions including administering the peptides, homologues, derivatives thereof and compositions including the same, are provided.
    Type: Application
    Filed: January 22, 2009
    Publication date: December 23, 2010
    Applicant: COMPUGEN LTD.
    Inventors: Yossef Kliger, Ofer Levy, Itamar Borukhov, Assaf Wool, Ehud Schreiber, Anat Amir, Zurit Levine, Zohar Tiran, Anat Oren, Amir Toporik
  • Publication number: 20100183573
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Application
    Filed: February 19, 2010
    Publication date: July 22, 2010
    Applicant: COMPUGEN LTD.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran, Dvir Dahary, Liat Mintz, Hanqing Xie
  • Patent number: 7758862
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Grant
    Filed: October 3, 2006
    Date of Patent: July 20, 2010
    Assignee: Compugen Ltd.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran
  • Patent number: 7678769
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Grant
    Filed: July 23, 2007
    Date of Patent: March 16, 2010
    Assignee: Compugen, Ltd.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran, Dvir Dahary, Liat Mintz, Hanqing Xie
  • Publication number: 20090036374
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Application
    Filed: October 3, 2006
    Publication date: February 5, 2009
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran
  • Publication number: 20080159992
    Abstract: Novel polypeptides that are splice variants of c-Met, the receptor for hepatocyte growth factor and polynucleotides encoding same are provided. Methods and pharmaceutical compositions which can be used to treat various disorders such as cancer, immunological-related, blood-related and skin-related disorders using the polypeptides and polynucleotides of the present invention, are also provided.
    Type: Application
    Filed: July 23, 2007
    Publication date: July 3, 2008
    Applicant: COMPUGEN LTD.
    Inventors: Galit Rotman, Merav Beiman, Michal Ayalon-Soffer, Zurit Levine, Chen Hermesh, Anat Oren, Zohar Tiran, Dvir Dahary, Liat Mintz, Hanqing Xie
  • Publication number: 20050123538
    Abstract: Isolated polynucleotides encoding novel ErbB-2 polypeptides are provided. Also provided are methods and kits using same for diagnosing prognosing and treating ErbB-related cancer.
    Type: Application
    Filed: October 4, 2004
    Publication date: June 9, 2005
    Inventors: Ronen Shemesh, Anat Oren, Galit Rotman, Osnat Sella-Tavor, Shira Walach, Shirley Sameach-Greenwald, Merav Beiman, Dani Eshel, Kinneret Savitsky
  • Publication number: 20050118615
    Abstract: The present invention concerns several splice variants of a Chordin like homologues (CHL2) and depicts their nucleic acid and amino acid sequences, vectors and host cells containing said nucleic acid sequences and antibodies reactive with the amino acid sequences. The invention also concerns pharmaceutical compositions for the treatment of a plurality of diseases, comprising nucleic acid sequences, amino acid sequences, expression vectors and antibodies. The invention also concerns methods for detecting the above nucleic acid or amino acid sequences or antibodies in a biological sample.
    Type: Application
    Filed: August 9, 2004
    Publication date: June 2, 2005
    Applicant: COMPUGEN LTD.
    Inventors: Anat Oren, Galit Rotman, Amir Toporoik, Sharon Biton, Kinneret Savitsky, Jeanne Bernstein